Eiger BioPharmaceuticals OverviewEiger BioPharmaceuticals Net Income
Profitability analysis for EIGR.
Quarterly Net Income
-$13.45M
↑ 46.48% YoY
As of Dec 2023
Annual Net Income (TTM)
-$74.96M
↑ 22.54% YoY
Trailing 12 months ending Dec 2023
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...